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Abstract: The objective of this study was to develop thin, biocompatible, and biofunctional 
hydrogel-coated small-sized nanoparticles that exhibit favorable stability, viability, and 
specific cellular uptake. This article reports the coating of magnetic iron oxide nanoparticles 
(MIONPs) with covalently cross-linked biofunctional polyethylene glycol (PEG) hydrogel. 
Silanized MIONPs were derivatized with eosin Y, and the covalently cross-linked biofunc-
tional PEG hydrogel coating was achieved via surface-initiated photopolymerization of PEG 
diacrylate in aqueous solution. The thickness of the PEG hydrogel coating, between 23 and 
126 nm, was tuned with laser exposure time. PEG hydrogel-coated MIONPs were further 
functionalized with the fibronectin-derived arginine-glycine-aspartic acid-serine (RGDS) 
sequence, in order to achieve a biofunctional PEG hydrogel layer around the nanoparticles. 
RGDS-bound PEG hydrogel-coated MIONPs showed a 17-fold higher uptake by the human 
cervical cancer HeLa cell line than that of amine-coated MIONPs. This novel method allows 
for the coating of MIONPs with nano-thin biofunctional hydrogel layers that may prevent 
undesirable cell and protein adhesion and may allow for cellular uptake in target tissues in 
a specific manner. These findings indicate that the further biofunctional PEG hydrogel coat-
ing of MIONPs is a promising platform for enhanced specific cell targeting in biomedical 
imaging and cancer therapy.
Keywords: PEG hydrogel, surface-initiated photopolymerization, nanoparticle encapsulation, 
agglomeration
Introduction
Nanoparticles are powerful candidates for current clinical diagnostics and thera-
peutic methods. Magnetic iron oxide nanoparticles (MIONPs) have a variety of 
applications in areas such as cancer and cardiovascular and neurological disorders.1 
Specifically, MIONPs have been exploited widely in biotechnology and medicine 
as delivery   systems for drugs, genes, and biomolecules; as imaging agents for the 
diagnosis of cancer; and for cell tracking and hyperthermia.2–8 In addition to in vivo 
applications, MIONPs are useful for various in vitro medical applications such as the 
magnetic   separation of cells, proteins, DNA/RNA, and other   biomolecules.2 Although 
MIONPs find extensive use in biomedicine and in various in vitro   applications, 
their   clinical use has been hindered because of agglomeration and fast detection via 
immune cells in physiological medium.2,9 MIONPs without any surface modification 
exhibit hydrophobic surface properties with a large surface area to volume ratio.9–11 
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These particles tend to agglomerate and form large clus-
ters,2,12 and because of this they are not appropriate for bio-
medical applications.2,9 Therefore, MIONPs for biomedical 
use are coated with an appropriate water-soluble organic 
materials to reduce or prevent agglomeration and to provide 
stability in physiological medium. Although some MIONPs 
have proper surface chemistry, they are prevented from 
reaching target tissue sites by some biological systems, such 
as the reticuloendothelial system, vascular endothelium, and 
blood–brain barrier.1 In order to overcome the problems 
associated with the tendency to aggregate and with fast 
blood clearance, biocompatible polymers such as polyeth-
ylene glycol (PEG)11 and polyvinylpyrrolidone12 are exten-
sively exploited as encapsulating materials for MIONPs. 
  Particularly, PEG-coated MIONPs demonstrate appropriate 
stability in a physiological   environment.2   Previous studies 
have shown that the coating of nanoparticles with PEG 
increases half-life of nanoparticles in the body.2,9,13 It has 
also been observed that the properties of coating material 
influence magnetic field strength of MIONPs. For example, 
dextran coating decreased the magnetic field strength of 
MIONPs because of the decreased interaction between 
iron oxide cores and water molecules.14 Therefore, unique 
strategies are required to enhance the uptake of MIONPs 
by cancer cells specifically without altering their magnetic 
properties.
PEG hydrogels are the most widely exploited three-
dimensional, hydrophilic, synthetic polymeric networks 
because of their resemblance to natural living tissue, their 
biocompatibility, and their resistance to cell and protein 
adhesion in vivo.15–17 PEG is approved by the US Food 
and Drug Administration as a material with extensive use 
in   biomaterials, biotechnology, and medicine.17–19 Because 
of these desirable properties, PEG and PEG hydrogels 
are commonly used for applications in tissue engineering 
as extracellular matrix mimics, or as the coating material 
for encapsulation of cells and nanoparticles.17,20–23 Hydrogel-
encapsulated nanoparticles have created a tremendous inter-
est because of their unique properties and broad applications, 
although conventional hydrogels have limited applications 
because of their poor mechanical strength.24,25 Recently, 
PEG hydrogel nanocomposite has been investigated as a 
potential implantable biomaterial for thermal cancer therapy 
  applications.22 The preparation of hydrogel nanocomposite 
involves incorporation of specific nanoparticle material within 
a hydrogel matrix in order to enhance properties of hydrogels 
or nanoparticles. Thus far, various nanoparticle-hydrogel 
composite systems comprising metallic nanoparticles, 
carbon nanotubes, clays, ceramics, magnetic nanoparticles, 
hydroxyapatite, or semiconducting nanoparticles have been 
reported.26–30 One of the advantages of hydrogel encapsula-
tion of nanoparticles is enhanced biocompatibility achieved 
through the presence of a hydrogel matrix between sensitive 
tissues and potentially harmful nanoparticles. For example, 
a recent study by Meenach et al22 demonstrated more favor-
able cell viability for iron oxide nanoparticles encapsulated 
within poly-N-isopropylacrylamide hydrogel than for unen-
capsulated nanoparticles.
Previous experimental studies with nanoparticle-hydrogel 
composite systems were based on bulk polymerization or 
incorporation of nanoparticles within an existing hydrogel 
matrix. Experimental efforts involving nanoencapsulation 
or coating of nanoparticles within a biofunctional PEG 
hydrogel capsule do not yet exist. This work reports, 
for the first time in the literature, the surface-initiated 
photopolymerization technique used for the encapsulation of 
single MIONPs or small clusters within a biofunctional PEG 
hydrogel. The objective of this study was to develop thin, 
biocompatible, and biofunctional hydrogel-coated small-
sized nanoparticles that exhibit favorable stability, viability, 
and specific cellular uptake. In order to achieve the individual 
or cluster coating of nanoparticles with a nano-thin PEG 
hydrogel layer via surface-initiated photopolymerization, 
we applied a technique previously developed by Kizilel 
et al18,31–34 (Figure 1A). PEG hydrogel was functionalized 
with arginine-glycine-aspartic acid-serine (RGDS) in 
order to achieve binding of the PEG hydrogel-coated 
MIONP structure to αvβ3 integrin, which is located at the 
outer cell membrane of the tumor endothelial cells.1,35,36 
Biofunctional PEG hydrogel-encapsulated MIONPs in a 
core-shell structure have a nanometer-sized diameter, which 
is composed of a magnetic core, a cross-linked PEG shell, 
and covalently bound RGDS domains. We hypothesized that 
an RGDS-functionalized PEG hydrogel coating may increase 
the efficiency of internalization of MIONPs at the tumor site 
and prevent agglomeration and cell and protein adhesion.19 
Another advantage of the method used here involves 
synthesis of small-sized and stable MIONPs through a 
3-aminopropyltrimethoxysilane (APTMS) coating, which 
enables ultrasmall MIONPs to be coated with PEG hydrogel 
and the covalent attachment of APTMS to the iron oxide 
surface, which enables a stable coating and foundation for 
photopolymerization.
After surface-modification steps, MIONPs were 
  characterized using Fourier transform infrared (FT-IR) 
spectroscopy, dynamic light scattering (DLS), zeta   potential 
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measurement, scanning electron microscopy (SEM), and 
atomic force microscopy (AFM). HeLa cells that were 
incubated with RGDS-functionalized PEG hydrogel-coated 
MIONPs demonstrated enhanced viability compared with 
those exposed to APTMS-coated or only PEG hydrogel-
coated MIONPs. Further, the biofunctional PEG hydrogel-
coated MIONP system was superior in terms of intracellular 
uptake compared to other systems containing APTMS-coated 
or only PEG hydrogel-coated nanoparticles, as shown via 
Prussian blue staining and inductively coupled plasma optical 
emission spectrometry (ICP-OES).
Material and methods
Materials
FeCl3 ⋅ 6H2O and FeCl2 ⋅ 4H2O were used as purchased from 
Fluka (Sigma-Aldrich, Taufkirchen, Germany).   Ammonium 
hydroxide (26% NH3 in water, w/w) was purchased from 
Riedel-de Haën (Hanover, Germany). APTMS was   purchased 
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Figure  1  (A)  Schematic  representation  of  the  coating  of  an  iron  oxide  nanoparticle  with  biofunctional  polyethylene  glycol  (PEG)  hydrogel  via  surface-initiated 
photopolymerization; (B) schematic representation of acrylate (Acr)-PEG-arginine-glycine-aspartic acid-serine (RGDS) synthesis. 
Abbreviation: MIONP, magnetic iron oxide nanoparticle.
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from Gelest, Inc (Morrisville, PA). Eosin Y (91%), 1-vinyl-
2-pyrrolidinone (VP; 99%), PEG diacrylate (PEGDA) (MW: 
575 Da), Woodward’s reagent K (WRK) (2-ethyl-5-phenylisox-
azolium-3′-sulfonate, 95%), phosphate-buffered saline (PBS), 
and Triton® X-100 were purchased from Sigma-Aldrich. Tri-
ethanolamine (TEA) (99.5%), sodium bicarbonate, and 37% 
formaldehyde were obtained from Merck (Whitehouse Sta-
tion, NJ). Hydrochloric acid (HCl) and sodium hydroxide were 
purchased from Riedel-de Haën. The Amicon Ultra centrifugal 
filter device (NMWL: 3000) was obtained from EMD Mil-
lipore (Billerica, MA). Short peptide RGDS (MW: 433 Da) 
was purchased from Elim Biopharmaceuticals, Inc (Hayward, 
CA). Acrylate PEG N-hydroxysuccinimide (acryl-PEG-NHS) 
(MW: 3.4 kDa) was purchased from Nektar (Huntsville, AL). 
The dialysis cassette (MW cutoff: 3.5 kDa) and bicinchoninic 
acid protein assay were purchased from Pierce (Micro BCA 
Protein Assay; Thermo Fisher Scientific Inc, Rockford, IL). 
Teflon syringe filters (0.2 µm pore size) were obtained from 
Nalgene (Rochester, NY). Petri dishes were purchased from 
Nunc (Roskilde, Denmark). Dulbecco’s modified Eagle 
medium (liquid, with 4.5 g/L D-glucose and sodium pyruvate) 
(DMEM), L-glutamine, and penicillin/streptomycin were 
purchased from Invitrogen Co (Carlsbad, CA). Fetal bovine 
serum was obtained from Biological Industries (Rainbow Sci-
entific, Inc, Windsor, CT). Trypsin-ethylenediaminetetraacetic 
acid was purchased from Genlantis, Inc (San Diego, CA). 
CellTiter-Glo® Luminescent Cell Viability Assay Kit was 
obtained from Promega (Madison, WI). Cell culture plates 
(96- and six-well) were purchased from Greiner Bio-One 
GmbH (Solingen, Germany). Ninety-six-well LUMITRAC® 
600 white immunology plates were obtained from USA 
  Scientific, Inc (Ocala, FL). Microscope slides were purchased 
from Fisher Scientific (CA). Cover slides were obtained from 
Isolab. Potassium ferrocyanide was purchased from Labkim 
(Istanbul, Turkey).
Synthesis of acryl-PEG-RGDS conjugate
The synthesis of acryl-PEG-RGDS conjugate was performed 
as represented in Figure 1B. Short peptide RGDS (1 mg/mL) 
solution and acryl-PEG-NHS (10 mg/mL) solution were 
prepared separately in 50 mM of sodium bicarbonate 
at pH 8.2. Acryl-PEG-NHS solution was added drop-wise to 
the peptide solution until the mole ratio of acryl-PEG-NHS 
to peptide was 1:1. The conjugation reaction was carried 
out for 2 hours at room temperature and with continuous 
rocking. After the reaction, the reaction mixture was 
dialyzed against deionized water in order to remove 
unreacted acryl-PEG-NHS and peptide.
The amount of acryl-PEG-RGDS in the conjugate   product 
was determined by bicinchoninic acid protein assay using 
a NanoDrop 1000 spectrophotometer (Fisher Scientific 
  (Austria) GmbH, Vienna, Austria) set at a wavelength of 
562 nm. The conjugate product included 70% acryl-PEG-
RGDS. The binding of RGDS peptide to acryl-PEG-NHS 
was confirmed by FT-IR spectroscopy (Nicolet iS10 FT-IR 
spectrometer; Fisher Scientific (Austria) GmbH).
Synthesis of APTMS-coated MIONPs
Milli-Q® (EMD Millipore) water (45 mL) was deoxygenated 
for 30 minutes in a 100 mL three-necked round-bottom flask 
fitted with a mechanical stirrer and a condenser. Iron salts 
(Fe3+/Fe2+ mole ratio, =2; total iron concentration, 0.175 M) 
were added to the flask and stirred at 400 rpm under nitrogen 
for about 15 minutes. The reaction flask was placed into 
an oil bath at 85°C. After 10 minutes of mixing, APTMS 
(Si/Fe mole ratio, 1.25) and excess amount of ammonium 
hydroxide were injected into the flask with vigorous stirring 
at 600 rpm. The reaction was allowed to continue for 1 hour 
to produce a stable colloidal solution; then it was cooled to 
room temperature and placed on top of a magnet (0.3 Tesla) 
for a few hours. Any precipitate was removed with magnetic 
decantation. Nanoparticles were washed using the Amicon 
Ultra centrifugal filter with deionized water. The amount of 
organic coating on MIONPs was calculated through thermo-
gravimetric analysis (TGA 50/50H, Shimadzu Deutschland 
GmbH, Duisburg, Germany) performed on dried powders.
Eosin binding onto the surface  
of MIONPs
Eosin solution (4 mM) in deionized water and WRK (20 mM) 
solution in sodium hydroxide (0.1 M) were prepared and 
the solutions were adjusted to pH 9. Equal volumes of both 
the eosin and the WRK solution were mixed and reacted for 
30 minutes. Equal volumes (10 mL) of 40 mg/mL aqueous 
APTMS-coated MIONPs and eosin-WRK mixture were 
reacted overnight at room temperature and at pH 9 in order 
to form amide bonds between the carboxylic acid group 
of eosin and the amine group of APTMS-coated MIONPs 
(final   reaction solution contained 20 mg/mL APTMS-coated 
MIONPs, 1 mM of eosin and 5 mM of WRK) (Figure 2A). 
Next, the eosin-bound MIONP solution was washed using 
the Amicon Ultra centrifugal filter with deionized water in 
order to remove unbound eosin, excess WRK, and other 
ions. The amount of eosin on the MIONPs was determined 
by the absorbance at 537 nm, using the Nanodrop 1000 
spectrophotometer.
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Figure 2 (A) Schematic representation of eosin binding onto the surface of amine-functionalized magnetic iron oxide nanoparticles (MIONPs); (B) encapsulation of eosin-
bound MIONPs within arginine-glycine-aspartic acid-serine (RGDS)-functionalized polyethylene glycol (PEG) hydrogel. 
Abbreviations: Acryl, acrylate; APTMS, 3-aminopropylsilane; WRK, Woodward’s reagent K.
Prepolymer solution preparation
Prepolymer solution (PPS) containing 6.25% PEGDA (w/v) 
(MW: 575 Da), TEA (141 mM), and VP (24 mM) was prepared 
in deionized water. The solution was adjusted to pH 8 using 
HCl (6 M). In order to produce an RGDS-functionalized PEG 
hydrogel coating around MIONPs, acryl-PEG-RGDS was 
added to the PPS at a final concentration of 1.48 × 10−5 M.
Hydrogel coating of MIONPs
The eosin-bound MIONP solution was mixed with the 
PPS in order to achieve a final concentration of 0.1 mg/mL 
eosin-bound MIONPs, 5% PEGDA, 19 mM of VP, 113 mM 
of TEA, and 1.48 × 10−5 M acryl-PEG-RGDS (for RGDS-
functionalized hydrogel-coated nanoparticles). The solution 
was adjusted to pH 8. Next, the mixture was illuminated with 
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green light at 514 nm and a flux of 2.5 mW/cm2 using an 
argon ion laser (Coherent Inc, Santa Clara, CA) at   various 
exposure times (20, 30, and 60 seconds) (Figure 2B). In 
order to remove unreacted PEGDA, acryl-PEG-RGDS, and 
other unreacted components, coated MIONPs were washed 
using the Amicon Ultra centrifugal filter. The washed coated 
MIONPs were stored at 4°C.
Structural, chemical, and physicochemical 
characterization of MIONPs
APTMS-coated,  eosin-bound,  and  PEG  hydrogel- 
encapsulated MIONPs with or without RGDS were charac-
terized in terms of structure, size, stability, and morphology. 
In order to investigate the crystal structure of APTMS-coated 
MIONPs and PEG hydrogel-coated MIONPs, X-ray dif-
fraction (XRD) was performed (Bruker AXS D8 Advance; 
Karlsruhe, Germany). FT-IR spectroscopy was used to 
follow changes in the chemical structure after each coating 
step. The hydrodynamic size of particles was determined 
using DLS at room temperature (Malvern zetasizer nano 
S  ZEN 1600, wavelength 633 nm; Malvern Instruments, 
Malvern, UK). The colloidal stability of nanoparticles 
was characterized through zeta potential analysis using a 
ZetaPALS (Brookhaven Instruments Corporation, Holts-
ville, NY). PEG hydrogel-coated MIONPs were physically 
adsorbed on a silicon surface and dried at 50°C for 1 hour, 
and the morphology of PEG hydrogel-coated MIONPs was 
analyzed via SEM (Zeiss Ultra Plus, Bruker; Optronik Ltd 
Sti, Ankara, Turkey) and the SOLVER S47 scanning probe 
microscopy platform (NT-MDT Europe BV , Eindhoven, The 
Netherlands) in intermittent AFM mode.
Evaluation of cytotoxicity  
of nanoparticles
The effect of nanoparticles on cell viability was investigated 
using HeLa cells. Cells were seeded at 5 × 104 cells/mL 
in a 96-well plate and cultured for 24 hours in DMEM 
(pH 7.4, with 10% fetal bovine serum, 1% penicillin/
streptomycin, and L-glutamine). Suspensions with 
APTMS-coated MIONPs, eosin-bound MIONPs, PEG 
hydrogel-coated MIONPs, and RGDS-functionalized PEG 
hydrogel-coated MIONPs were added to the HeLa cell 
culture medium at separate concentrations of 0.01, 0.05, 
and 0.1 mg/mL. After 24 and 48 hours of incubation, the 
CellTiter-Glo Luminescent Viability Assay was carried 
out using a Fluoroskan Ascent luminescence reader (Fisher 
Scientific (Austria) GmbH).
Characterization of internalization  
of nanoparticles by Prussian blue staining
Intracellular uptake of APTMS, PEG hydrogel-coated MIONPs, 
and RGDS-functionalized PEG hydrogel-coated MIONPs were 
characterized via Prussian blue staining. HeLa cells (5 × 106) 
were cultured for 24 hours in six-well plates on glass coverslips. 
After uniform attachment of HeLa cells on the slide surface 
was achieved, nanoparticles at a concentration of 0.1 mg/mL 
were added into each well. After 24 hours of incubation, the 
HeLa cells on the cover slides were washed three times with 
PBS and fixed with 4% formaldehyde for 20 minutes at room 
temperature. After fixation the cells were treated with 0.1% 
Triton X-100 for 5 minutes and rinsed with PBS for permea-
bilization, and this step was repeated four times. Next, fixed 
HeLa cells were incubated in 5% potassium ferrocyanide and 
10% HCl for 15 minutes. Finally, iron staining was observed 
via a camera equipped for optical microscopy (Motic DM-B1 
Optical Microscope, Motic, Wetzlar, Germany).
Determination of intracellular  
iron content
Cellular uptakes of nanoparticles were determined   qualitatively 
via ICP-OES. HeLa cells were grown in DMEM in a 24-well 
plate (105 cells in 1 mL of medium; 1 mL of cell   culture 
was added into each well). After 24 hours of incubation, 
APTMS, PEG hydrogel-coated and RGDS-functionalized 
PEG   hydrogel-coated MIONPs were added into the medium 
at a concentration of 0.1 mg/mL. In control samples the cells 
were placed in medium (1 mL) without nanoparticles by 
using the same cell density. After 24 hours of treatment of 
cells with nanoparticles, cells were rinsed three times with 
PBS. Cells were detached from the surface via trypsin-ethyl-
enediaminetetraacetic acid solution (0.25 mL in each well). 
Detached cells were incubated in a mixture of 65% nitric acid 
(0.25 mL) and 30% hydrogen peroxide (0.25 mL) for 24 hours 
at 90°C. Finally, ICP-OES analysis was carried out for all 
samples, using an inductively coupled plasma optical emission 
spectrometer (SPECTRO GENESIS; SPECTRO Analytical 
Instruments GmbH, Kleve, Germany). Reported values were 
averages of three runs and three samples.
Statistical analysis
The results of all data sets were analyzed using one-way analy-
sis of variance. The results are represented as the mean value 
(plus or minus standard deviation) of the   triplicate samples 
unless otherwise stated. Differences between datasets are con-
sidered statistically significant for P-values less than 0.05.
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Results
Synthesis of acryl-PEG-RGDS conjugate
Covalent conjugation of RGDS peptide with acryl-PEG-NHS 
was confirmed with FT-IR spectroscopy. Carbonyl groups 
(C=O) in NHS ester exhibit two peaks at 1781 cm−1 and 
1820 cm−1.37 After conjugation reaction, the disappearance 
of these carbonyl bands confirms that NHS ester reacted with 
the amine groups in the RGDS structure, and new amide 
bonds were formed (Figure S1). The peak corresponding to 
the carbonyl group in acryl-PEG-NHS was observed around 
1740 cm−1. After the conjugation reaction, the amide I peak 
appeared at 1670 cm−1.38 This new peak is clear evidence 
for the presence of RGDS in acryl-PEG-RGDS conjugate.
Synthesis and characterization  
of MIONPs
Stable and ultrasmall (6.4 nm in hydrodynamic size) aque-
ous MIONPs were synthesized with 20% (w/w) of APTMS 
coating. The XRD pattern of the APTMS-coated iron oxide 
nanoparticles exhibit a typical six-peak pattern39 that fits well 
with a maghemite-like structure – more specifically, Fe2.67O4 
(Figure 3A). Ultraviolet and visible (UV-Vis) spectra of APTMS-
coated and eosin-bound MIONPs (washed) are provided in 
Figure S2A. The appearance of a new peak in the UV-Vis spectra 
of eosin-bound MIONPs around 530 nm confirmed eosin bind-
ing on APTMS-coated MIONPs.   Absorbance of eosin-bound 
MIONPs at 530 nm indicated 0.57 mM eosin concentration 
on the nanoparticle surface.40 This value corresponds to 57% 
efficiency in eosin binding to the MIONP surface.
The binding of eosin onto the surface of APTMS-coated 
MIONPs was also confirmed by FT-IR spectroscopy analysis. 
Figure S2B shows FT-IR spectra of both APTMS-coated 
and eosin-bound MIONPs. MIONPs exhibited two peaks at 
571 cm−1 and 590 cm−1 because of the iron oxide cores.41–43 
The peaks at 919, 1215, 1328, 1388, 1505, 1617, and 
2931 cm−1 were assigned to C–H out-of-plane bending, 
aliphatic C–N stretching, aliphatic C–O stretching, Si–CH2 
scissoring, C–H bending, NH2 scissoring and N–H bending, 
and CH2 stretching, respectively.41,44,45 After eosin binding, 
new bands that appeared at 1456 cm−1 and 1541 cm−1 cor-
responded to aromatic C=C stretching of eosin. These new 
peaks overlapped with the C–H bending peak at 1505 cm−1. 
The peaks at 3058 and 3352 cm−1 belonged to NH2 stretching 
of the APTMS-coated MIONPs.45 This feature disappeared 
to a great extent, and one new peak at 3156 cm−1 that corre-
sponded to secondary amide N–H stretching appeared after 
the eosin binding.45 These two FT-IR spectra gave strong 
evidence about covalent binding of eosin to the amine groups 
of APTMS-coated MIONPs.
After the photopolymerization reaction, characteristic eosin 
absorbance at 517 nm disappeared in the UV-Vis spectra of 
PEG hydrogel-coated MIONPs (Figure S3). This is expected 
as a result of eosin bleaching during light exposure. The pres-
ence of PEG and RGDS peptides on MIONPs was shown 
with FT-IR spectra (Figure 4). After PEG hydrogel coating, 
new bands seen at 1100 and 1352 cm−1 indicated symmetric 
and antisymmetric C−O−C stretching bands, respectively. 
The peaks at 1724 and 2850 cm−1 were assigned to C−H 
out-of-plane bending, C=O stretching and CH2 stretching, 
respectively. In the FT-IR spectra of PEG hydrogel-coated 
samples, the magnitude of the C=C stretching band peak at 
1640 cm−1 was decreased, which indicated the consumption 
of the double bonds during the photocrosslinking reaction. 
After the addition of acryl-PEG-RGDS conjugate, amide I 
10000
APTMS
coated
MIONPs
Magnet
8000
6000
4000
02 04 0
AB
2 theta
I
n
t
e
n
s
i
t
y
60 80
Figure 3 (A) X-ray diffraction patterns of 3-aminopropylsilane (APTMS)-coated 
magnetic  iron  oxide  nanoparticles  (MIONPs);  (B)  ferrofluid  under  an  external 
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Figure  4  Fourier  transform  infrared  spectra  of  (1)  polyethylene  glycol  (PEG) 
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hydrogel-coated  magnetic  iron  oxide  nanoparticles  functionalized  with  arginine-
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peak appeared at 1670 cm−1 – this peak was not observed in 
the remaining groups. The XRD pattern of PEG hydrogel-
coated MIONPs agreed well with the initial crystal structure. 
Although the existence of amorphous PEG coating prevented 
detection of sharp peaks in the XRD, original magnetite peaks 
(seen in Figure 3) could be observed in the diffraction pattern 
(Figure S4A).   Additionally, lyophilized PEG hydrogel-coated 
MIONPs responded well to an external magnet (Figure S4B). 
  Determination of the number of incorporated RGDS peptides 
per nanoparticle is technically challenging.46 Previously, Hern 
and Hubbell47 found a correlation between the percentage of 
acrylated peptide incorporation and acrylated peptide in PPS via 
radiolabeling assay. Using Hern and Hubbell’s47 results and 
based on our experimental acryl-PEG-RGDS and PEGDA 
concentrations in PPS, it was found that 17.8% acryl-PEG-
RGDS is incorporated into the PEG hydrogel structure. This 
means that 0.1 mg/mL of biofunctional PEG hydrogel-coated 
MIONPs contains 2.6 × 10−6 M PEG-RGDS conjugate.
The change in hydrodynamic size after each modifica-
tion step was characterized via DLS. Size distribution of 
MIONPs in all groups is shown in Figure 5A. Diameter of 
APTMS-coated MIONPs was 6.4 nm. After eosin binding 
on MIONPs, particle diameter increased to 12.6 nm. When 
eosin-bound MIONPs were added to PPS, hydrodynamic 
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size was   measured as 13.6 nm. The diameter of particles 
increased as a function of irradiation time: PEG hydrogel-
coated MIONPs at diameters of 23.3, 58, and 122 nm were 
obtained at 20, 30, and 60 seconds of laser exposure times, 
respectively. No significant change in the hydrodynamic size 
was observed with the incorporation of acryl-PEG-RGDS 
conjugate into the PEG hydrogel coating for samples irradi-
ated for 20 and 30 seconds. The increase in hydrodynamic 
size after each step of coating is summarized in Figure 5B.
Zeta potential measurement results show changes in 
surface charge of MIONPs during each step of their coating 
(Figure 6). Initially, APTMS-coated MIONPs had a typical 
positive zeta potential. After negatively charged eosin was 
bound onto the surface of the MIONPs, the total charge of the 
nanoparticles was changed from positive (22.3 mV) to almost 
neutral (2.3 mV). PEG hydrogel-coated MIONPs became 
negatively charged (about −30 mV), which is similar to the 
value obtained with pure PEGDA solution (−28 mV). The 
addition of PEG-RGDS conjugate did not affect the surface 
charge significantly.
After the coating of MIONPs with PEG hydrogel, SEM 
and AFM were used to characterize the morphology of 
the MIONPs. Figure 7 shows a SEM image of MIONPs 
coated with PEG hydrogel and with a laser exposure time of 
20 seconds. The particles are spherically shaped and have an 
average diameter of 35 ± 12 nm, which is consistent with the 
value measured with DLS. AFM height images (Figure S5A 
and B) demonstrate that many nanoparticles were coated 
individually but several nanoparticles were encapsulated in 
clusters.
Cytotoxicity and cellular  
uptake of MIONPs
In order to evaluate the toxicity of coated MIONPs, the 
viability of HeLa cells was examined after 24 and 48 hours 
of treatment with MIONPs at concentrations of 0.01, 0.05, 
and 0.1 mg/mL (Figure 8). At low MIONP concentration 
(0.01 mg/mL), the viability was .80% for cells treated with 
MIONPs in different groups. At higher concentrations (0.05 
and 0.1 mg/mL), samples of eosin-coated MIONPs and of 
MIONPs coated with PEG hydrogel and with 20 seconds 
of laser exposure time had a toxic effect on HeLa cells 
cultured for 24 and 48 hours. This was probably because 
of the presence of unreacted pendant groups in the system 
and could possibly be eliminated via repeated swelling and 
lyophilization of MIONPs. When laser exposure time for 
photopolymerization was increased from 20 seconds to 
30 and 60 seconds, the PEG hydrogel coating did not affect 
cell viability significantly. The viability remained above 
80% for cells in the groups that were treated with the highest 
nanoparticle concentration (0.1 mg/mL).
Prussian blue staining and ICP-OES assays were used to 
compare intracellular uptake of MIONPs in different groups. As 
shown in Figure S6, MIONPs coated with RGDS-functionalized 
PEG hydrogel and with 60 seconds of illumination time 
demonstrated a blue granule appearance stronger than the 
intensity of blue color observed in other groups. This indi-
cates higher intracellular Fe concentration than the other 
conditions, with both APTMS or only PEG hydrogel-coated 
MIONPs. ICP-OES results also indicated a dramatic increase 
in the iron content of HeLa cells incubated with RGDS-
functionalized PEG hydrogel-coated MIONPs (60 seconds 
of illumination time) (Figure 9). RGDS-functionalized 
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Figure 6 Zeta potential measurement before and after polyethylene glycol (PEG) 
hydrogel coating: (1) 3-aminopropylsilane-coated magnetic iron oxide nanoparticles 
(MIONPs),  (2)  eosin,  (3)  eosin-bound  MIONPs,  (4)  PEG  diacrylate,  (5)  eosin-
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(7)  PEG  hydrogel-coated  MIONP-30,  (8)  PEG  hydrogel-coated  MIONP-60,  (9) 
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Note:  Numbers  in  abbreviations  MIONP-20,  MIONP-30,  MIONP-60  indicate 
corresponding illumination times in seconds.
Figure  7  Microscopic  characterization  of  polyethylene  glycol  hydrogel-coated 
magnetic iron oxide nanoparticles with an illumination period of 20 seconds: scanning 
electron microscopy image (scale bar: 200 nm) (20 kV; magnification: 75 KX).
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PEG hydrogel coating with 60 seconds of illumination time 
increased iron internalization into HeLa cells from 3 pg 
Fe/cell to 50 pg Fe/cell.
Discussion
Various strategies for coating MIONPs in order to prevent 
agglomeration and to increase blood circulation time have 
been developed using natural and synthetic polymers such 
as alginate,42 dextran,48 liposome,39 polyvinylpyrrolidone,12 
and PEG.41,43 Some of the limitations involved in the existing 
approaches are lack of stabilization in body fluid, difficulty 
reaching targeted cell types, and difficulty retaining suffi-
cient magnetic property. In order to address these limitations, 
starting from ultrasmall stable MIONPs, coating of particles 
with covalently cross-linked biofunctional PEG hydrogel has 
been investigated in this study. From the particle perspective, 
size of the biofunctional PEG hydrogel-coated MIONPs can 
be adjusted by changing the laser illumination time, and 
hydrodynamic size can be kept within “small size” regi-
men. The in vitro results of this study show that coating of 
nanoparticles using surface-initiated photopolymerization of 
PEGDA does not compromise viability of HeLa cells. Further, 
biofunctionalization of PEG hydrogel coating with RGDS 
using an illumination time of 60 seconds significantly increases 
the efficiency of uptake of MIONPs by HeLa cells.
Recent studies have demonstrated that a PEG   coating 
minimizes the intracellular uptake of nanoparticles by 
macrophages49 and increases circulation time in blood.50 
In this work, MIONPs were coated with cross-linked PEG 
hydrogel in order to improve stability and achieve high 
water content around nanoparticles. Furthermore, the use 
of PEG hydrogel systems allows for a flexible skeleton for 
nanoparticle biofunctionalization, because a specific ligand 
or therapeutic agent can be incorporated into PEG hydrogel 
during photopolymerization with this technique. Peptides that 
bind to the cell surface are functional tools for targeting the 
vascular endothelium in solid tumors for specific delivery of 
therapeutic and imaging agents.36 Thus, covalent conjuga-
tion of cell adhesion peptides to PEG hydrogel is a promis-
ing method for solving obstacles such as transportation 
and internalization of MIONPs into targeted specific cell 
types. Therefore, in the present study, PEG hydrogel was 
functionalized via acryl-PEG-RGDS conjugate in order to 
enhance accumulation and internalization of MIONPs into 
cancer cells. The conjugation reaction between peptide and 
PEG was carried out successfully, and was verified by FT-IR 
spectroscopy (Figure S1).
The XRD pattern of APTMS-coated MIONPs confirms 
their crystallinity (Figure 3A). As expected, the black-
brown aqueous suspension of these particles responded to 
an external magnetic field generated by a handheld magnet 
(Figure 3B). The photoinitiator eosin is covalently bound 
on APTMS-coated MIONPs with 57% efficiency using 
WRK chemistry. UV-Vis spectra and FT-IR spectra of both 
APTMS-coated and eosin-bound MIONPs confirmed the 
amidation reaction between the carboxyl group of eosin 
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and amine groups of APTMS-coated MIONPs (Figure 
S2A and B). Acryl-PEG-RGDS conjugate and eosin-bound 
MIONPs were added to the PPS and reacted via photopo-
lymerization at mild conditions at different time intervals 
in order to tune the hydrogel thickness around MIONPs. 
According to the FT-IR spectra in Figure 4, the peaks for 
C–O–C, CH2, and C–H gave strong evidence about the 
surface coverage of MIONPs with PEG hydrogel. Further, 
the FT-IR spectrum for the RGDS-functionalized PEG 
hydrogel-coated MIONPs demonstrated conjugation of 
acryl-PEG-RGDS conjugate within the cross-linked struc-
ture, which resulted in a biofunctional PEG hydrogel (Fig-
ure 4). Figure S4A shows PEG hydrogel-coated MIONPs 
retained their magnetic properties. The freeze-dried form of 
PEG hydrogel-coated particles could respond to an external 
magnetic field generated by a handheld magnet as expected 
(Figure S4B). Hence, PEG hydrogel did not disrupt the 
magnetic strength of the iron oxide nanoparticles. Protec-
tion of magnetic field property was also observed in previ-
ous studies performed with PEG coating of MIONPs.14,41 
In addition, bulk encapsulation of MIONPs within PEG 
hydrogel was studied by Meenach et al22 and magnetic 
property was shown to be preserved.
Pharmacokinetics and cellular uptake of nanoparticles 
are primarily based on physicochemical features such as 
hydrodynamic size, surface charge, and morphology.51 
In the present study, hydrodynamic size of nanoparticles 
before and after the coating steps was characterized by 
DLS, which is based on analyzing the diffusion behavior 
of the nanoparticles in solution.52 Figure 5A and B shows 
that increasing the illumination time also increased the 
thickness of the PEG hydrogel coating around the MIONPs 
– narrow size distribution could be obtained for nanoparticles 
in different groups. In addition, biofunctionalization 
of PEG hydrogel with the addition of acryl-PEG-RGDS into 
the PPS did not change the coating thickness or particle size 
distribution significantly. The electrostatic interactions of the 
nanoparticles could be characterized by their surface charge, 
which is analyzed via zeta potential measurement.53 The 
surface charge of the MIONPs before and after the coating 
steps was characterized via zeta potential measurement 
(Figure 6). The results obtained from DLS and zeta potential 
measurement suggest that PEG hydrogel-coated MIONPs 
can have extended stability in aqueous solution as a result 
of the electrostatic repulsion between negatively charged 
nanoparticles. The zeta potential results also suggest 
that PEG hydrogel coating may prevent aggregation of 
these nanoparticles during circulation in blood. The 
surface topography of PEG hydrogel-coated MIONPs was 
characterized via SEM (Figure 7) and AFM (Figure S5). 
Comparison of AFM height (Figure S5A and B) and phase 
images (Figure S5C and D) shows the core-shell structure of 
nanoparticles. The particles had an inner magnetite core and 
an outer polymeric shell of PEG, which provides additional 
evidence for the presence of PEG hydrogel on the surface 
of MIONPs. It was observed that some nanoparticles were 
encapsulated in clusters. Encapsulation of nanoparticles 
in groups could not be completely eliminated because the 
nanoparticles were tightly packed within the PPS. Size and 
surface modification of nanoparticles could result in a different 
response of cells to nanoparticles in terms of nonspecific or 
targeted cellular uptake.54 With the method presented here, 
it is possible to control the thickness and cross-link density 
of the hydrogel coating around nanoparticles through laser 
illumination time and/or monomer concentration. Further, 
various ligands or biomolecules could be covalently 
conjugated into a PEG hydrogel coating, which may also 
allow for specific cell targeting.
Toxicity is an important property to consider when 
evaluating the performance of nanoparticles for biomedical 
applications.3,55 Cytotoxic agents could compromise the 
viability of many cells within 48 hours of treatment.55 In 
this study, the viability of HeLa cells was characterized 
by exposing the cells to nanoparticles in different groups. 
Figure 8 shows that the PEG hydrogel coating of nanoparticles 
at laser illumination times of 30 and 60 seconds, with or 
50
40
30
20
10
0
1 2345 6
Samples
F
e
 
u
p
t
a
k
e
 
[
p
g
 
F
e
/
c
e
l
l
]
Figure 9 Uptake of magnetic iron oxide nanoparticles (MIONPs) by HeLa cells 
after 24 hours of incubation, as measured by inductively coupled plasma optical 
emission spectrometry: (1) control, (2) 3-aminopropylsilane-coated MIONPs, (3) 
polyethylene glycol (PEG) hydrogel-coated MIONP-30, (4) PEG hydrogel-coated 
MIONP-30  functionalized  with  arginine-glycine-aspartic  acid-serine,  (5)  PEG 
hydrogel-coated MIONP-60, and (6) PEG hydrogel-coated MIONP-60 functionalized 
with arginine-glycine-aspartic acid-serine. 
Note: Numbers in abbreviations MIONP-20, MIONP-30, and MIONP-60 indicate 
corresponding illumination times in seconds.
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without RGDS, did not affect cell viability significantly for 
either 24 or 48 hours of treatment.
The ability to deliver effective concentrations of 
therapeutic agents into the tumor site is a significant step 
towards the diagnosis and treatment of tumor or cancer 
tissue.56 The ligand-receptor approach provides medical 
intervention to influence cancer cells only, not the healthy 
cells, depending on the molecular identification system.56 
This approach also has great potential to enhance the 
efficiency of therapeutic and contrast agents, by increas-
ing the amount of those agents around the target site and 
by decreasing systemic administration, which reduces or 
prevents cytotoxicity or background signal imaging. Also, 
this method may identify the tumor at an earlier phase than 
the currently existing approaches and eliminate an invasive 
biopsy requirement.
In order to demonstrate whether intracellular uptake of 
biofunctional PEG hydrogel-coated nanoparticles by cancer 
cells will be affected by the coating, the authors used Prussian 
blue staining and ICP-OES measurements after 24 hours 
of incubation of HeLa cells with nanoparticles (Figures 9 
and S6). Figure 9 demonstrates that RGDS-functionalized 
PEG hydrogel-coated MIONPs with 60 seconds of laser 
illumination time had a 17-fold higher uptake by the HeLa 
cells than that of APTMS-coated MIONPs. These results 
suggest that RGDS was critical for cellular uptake and that 
PEG hydrogel formed with 60 seconds of laser illumination 
time was optimal for the biocompatibility of MIONPs at 
high concentration. Comparison of the cytotoxicity and 
cellular uptake results of PEG hydrogel-coated MIONPs with 
60 seconds of laser illumination time suggested that the PEG 
coating prevented interaction between MIONPs and cells 
and that the RGDS-functionalized PEG hydrogel coating 
provided internalization of MIONPs into cells. Based on 
viability results, it was observed that RGDS-functionalized 
PEG hydrogel-coated nanoparticles affected cell viability 
minimally at the highest nanoparticle concentration   
(0.1 mg/mL) and they displayed the highest cellular uptake. 
After biodegradation of MIONPs, cells could be exposed to 
excessive free iron. Free iron accumulation at high levels 
results in toxicity.57 The cross-linked structure of PEG 
coating may allow for slow diffusion of iron ions after 
biodegredation. This feature of PEG hydrogel can prevent 
high iron exposure in tissues of the target area. Therefore, an 
RGDS-functionalized PEG hydrogel coating may not only 
enhance internalization of nanoparticles but also prevent 
accumulation of excessive free iron by means of its cross-
linked network.
RGDS functionalization of the PEG hydrogel coating 
around nanoparticles also has a potential use in hyperthermia 
therapy, which involves raising the local temperature at the 
tumor site to promote cell death when MIONPs are exposed 
to an external magnetic field.6,19,58,59 In order to kill cancer 
cells efficiently by heating, this technique requires optimal 
particle size and tumor targeting. Nanoparticles must be fast, 
specific, and effective to reach the target site and to be taken 
up by tumor cells.60 Their performance in vivo is restricted 
by several factors such as aggregation, short half-life in 
blood circulation, inefficient cellular uptake, and nonspecific 
targeting.60 The size of MIONPs coated with biocompatible 
materials should be controlled in order to overcome difficul-
ties involved in their transport and internalization by specific 
cells. Based on the results obtained in this study, the biofunc-
tional PEG hydrogel coating of MIONPs offers a promising 
platform for in vivo applications. Not only may this approach 
allow specific tissues in the body to be targeted but also it 
may reduce the quantity of diagnostic or therapeutic agents 
necessary for achieving a particular concentration within the 
surroundings of the target tissue.
Conclusion
MIONPs have enormous potential for the early detection 
of cancer or tumor and for targeted therapies. In order to 
overcome the limitations associated with MIONP technolo-
gies, the authors have utilized a novel strategy of surface-
initiated photopolymerization to coat nanoparticles with 
RGDS-functionalized PEG hydrogel. The coating of MIONPs 
within biofunctional PEG hydrogel resulted in increased uptake 
by HeLa cells and increased viability of cells compared to the 
uptake and viability measured in control groups. Not only this 
method is applicable to the coating of iron oxide nanoparticles 
but it can also be extended to encapsulate nanoparticles with 
different geometries, such as nanorods, or chemistry, such as 
fullerenes. The strategy used in this study to coat nanoparticles 
may also be a significant tool for diagnostic and therapeutic 
imaging technologies to utilize for increasing blood circulation 
time and achieving the targeted delivery of drugs.
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Figure S1 Fourier transform infrared spectra of (1) acrylic acid N-hydroxysuccinimide, (2) acrylate-polyethylene glycol-N-hydroxysuccinimide, (3) acrylate-polyethylene glycol-
arginine-glycine-aspartic acid-serine, and (4) arginine-glycine-aspartic acid-serine.
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Figure S2 (A) Ultraviolet and visible spectra of (1) eosin only, (2) eosin-bound magnetic iron oxide nanoparticles (MIONPs), and (3) 3-aminopropylsilane-coated MIONPs; 
(B) Fourier transform infrared spectra of (1) 3-aminopropylsilane-coated MIONPs and (2) eosin-bound MIONPs.
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Figure S3 Photobleaching of eosin after photopolymerization: (1) eosin only; (2) arginine-glycine-aspartic acid-serine-functionalized polyethylene glycol hydrogel-coated magnetic 
iron oxide nanoparticles (MIONPs); (3) polyethylene glycol hydrogel-coated MIONPs; (4) eosin-bound MIONPs in prepolymer solution before photopolymerization reaction.
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Figure S5 (A) Atomic force microscopy (AFM) height image of a 5 µm2 area; (B) AFM height image of a 2 µm2 area; (C) AFM phase image of a 5 µm2 area; and (D) AFM 
phase image of a 2 µm2 area.
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Figure S4 (A) X-ray diffraction patterns of (1) lyophilized polyethylene glycol (PEG) hydrogel and (2) lyophilized PEG hydrogel-coated magnetic iron oxide nanoparticles 
(MIONPs); (B) lyophilized PEG hydrogel-coated MIONPs under the magnetic field of a magnet.
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Figure S6 HeLa cells stained with Prussian blue: (A) control; (B) 3-aminopropylsilane-coated magnetic iron oxide nanoparticles (MIONPs); (C) polyethylene glycol hydrogel-
coated MIONP-60; (D) arginine-glycine-aspartic acid-serine-functionalized polyethylene glycol hydrogel-coated MIONP-60 (scale bar: 25 µM). 
Note: Number in abbreviation MIONP-60 indicates corresponding illumination time in seconds.
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